Tranzyme Pharma Inc.
Sherbrooke, QC
Company Overview
NoKimia, Inc. is a chemistry-based drug discovery company that integrates advanced synthesis and combinatorial chemistry capabilities with computational methods to produce libraries of novel, potentially bioactive molecules. The main component of the highly versatile, patented NoKimia technology portfolio is the design and synthesis of conformationally defined, sophisticated macrocyclic molecules. The technology further has wide application at multiple stages in a drug discovery strategy: target validation, lead identification and activity optimisation
NoKimia's primary mission is to develop and exploit unique chemical technologies to discover novel lead compounds that can be optimized to produce preclinical candidates for drug development
Company Information
Physical Address
3001-12e av. N.
Sherbrooke, QC J1H 5N4
CA
Mailing Address
3001-12e av. N.
Sherbrooke, QC J1H 5N4
CA
Additional Details
Legal Name: Tranzyme Pharma Inc.
Number of Employees: 22
CA
Une plaque-forme technologique qui permet de dvelopper des molcules haute valeur ajoute.
6000 pi, carr
17-recherches 5-administration
Contacts
Mark L. Peterson
Title: Director
Area of Responsibility: Research/Development/Engineering
Phone: Show phone
Fax: Show fax
Email: Show email
Graeme Fraser
Title: Director
Area of Responsibility: Research/Development/Engineering
Phone: Show phone
Fax: Show fax
Email: Show email
Products
- Biotechnology
- Recherche Et Dveloppement
Additional Information
541710
United Kingdom, United States